Insider Trading & Ownership - Buten Matthew

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Buten Matthew
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-10-05
Purchase
2023-10-06
07:38 am
Biohaven Ltd.BHVNButen Matthew
Chief Financial Officer
22,727$22$499,994189,380
(Direct)
View
2022-10-25
Purchase
2022-10-26
6:21 pm
Biohaven Ltd.BHVNButen Matthew
Chief Financial Officer
142,857$10.5$1,499,999166,653
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-02
Option Award
2024-01-04
8:07 pm
N/A
2034-01-02
Biohaven Ltd.BHVNButen Matthew
Chief Financial Officer
96,250$096,250
(Direct)
View
2023-11-02
Option Award
2023-11-06
8:34 pm
N/A
2033-11-02
Biohaven Ltd.BHVNButen Matthew
Chief Financial Officer
78,750$078,750
(Direct)
View
2022-10-03
Tax Withholding
2022-10-05
5:36 pm
N/A
N/A
Biohaven Ltd.BHVNButen Matthew
Chief Financial Officer
11,042$7.5358,634
(Direct)
View
2022-10-03
Other
2022-10-05
5:36 pm
N/A
2032-01-07
Biohaven Ltd.BHVNButen Matthew
Chief Financial Officer
34,838$0358,634
(Direct)
View
2022-10-03
Exercise
2022-10-05
5:36 pm
N/A
N/A
Biohaven Ltd.BHVNButen Matthew
Chief Financial Officer
13,000$6.37358,634
(Direct)
View
2022-10-03
Exercise
2022-10-05
5:36 pm
N/A
2032-01-07
Biohaven Ltd.BHVNButen Matthew
Chief Financial Officer
13,000$0358,634
(Direct)
View
2022-10-03
Option Award
2022-10-05
5:36 pm
N/A
2032-10-04
Biohaven Ltd.BHVNButen Matthew
Chief Financial Officer
300,000$0358,634
(Direct)
View
2022-10-03
Disposition
2022-10-03
8:28 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNButen Matthew
Chief Financial Officer
6,177$148.50
(Direct)
View
2022-10-03
Disposition
2022-10-03
8:28 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNButen Matthew
Chief Financial Officer
63,500$00
(Direct)
View

Ownership
2022-09-28
8:51 pm
N/A
N/A
Biohaven Ltd.BHVNButen Matthew
Treasurer
0$00
(Direct)
View
2022-01-07
Option Award
2022-01-07
9:19 pm
N/A
2032-01-07
Biohaven Pharmaceutical Holding Co Ltd.BHVNButen Matthew
Chief Financial Officer
26,000$026,000
(Direct)
View
2021-12-31
Exercise
2022-01-04
9:30 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNButen Matthew
Chief Financial Officer
12,500$043,677
(Direct)
View
2021-12-31
Tax Withholding
2022-01-04
9:30 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNButen Matthew
Chief Financial Officer
6,323$137.8143,677
(Direct)
View
2021-12-08
Option Award
2021-12-14
8:52 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNButen Matthew
Officer
50,000$050,000
(Direct)
View